Loss- and gain-of-function studies of FOXE1 in thyroid cancer cells show that FOXE1 may be an EMT modulator (Morillo-Bernal, Fernandez, and Santisteban 2020). The gene discussed is FOXE1; the disease is thyroid gland carcinoma.